Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print October 14, 2004, 10.1148/radiol.2333031617
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2333031617v1
233/3/682    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Awai, K.
Right arrow Articles by Yamashita, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awai, K.
Right arrow Articles by Yamashita, Y.
(Radiology 2004;233:682-688.)
© RSNA, 2004

Contrast Media

Moderate versus High Concentration of Contrast Material for Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast at Multi–Detector Row CT1

Kazuo Awai, MD, Masaaki Inoue, MD, Yukinobu Yagyu, MD, Manabu Watanabe, MD, Toshiko Sano, MD, Seiun Nin, MD, Ryuta Koike, MD, Yasumasa Nishimura, MD and Yasuyuki Yamashita, MD

1 From the Department of Radiology, Kinki University School of Medicine, 2–23 Ono-higashi, Osaka-Sayama, Osaka 589-8511, Japan (K.A., M.I., Y. Yagyu, M.W., T.S., S.N., R.K., Y.N.); and Department of Radiology, Kumamoto University Graduate School of Medical Science, Kumamoto, Japan (Y. Yamashita). Received October 10, 2003; revision requested December 30; revision received February 12, 2004; accepted March 26. Address correspondence to K.A.

PURPOSE: To prospectively evaluate aortic and hepatic enhancement and depiction of hypervascular hepatocellular carcinoma (HCC) between two contrast materials with moderate and high iodine concentrations when administered at same iodine dose and injection duration at multi–detector row helical computed tomography (CT).

MATERIALS AND METHODS: Institutional review board approval and informed patient consent were obtained. One hundred eighty-six patients were studied, and 67 patients with hypervascular HCC were identified. Ninety-four patients were assigned to receive iohexol 350 (mg iodine per milliliter) with protocol A; 92, iohexol 300 with protocol B. In both protocols, iohexol with same iodine load per weight (518 mg/kg) was administered with same injection duration (25 seconds). Multiphase CT scanning was started 10, 20, 50, and 180 seconds after the trigger (threshold level set at increase of 100 HU over baseline CT number of aorta). Enhancement of aorta and liver was measured in 186 patients. Tumor-to-liver contrast was measured in 67 patients with hypervascular HCC. Statistical analysis was performed with Mann-Whitney U test.

RESULTS: Medians of aortic enhancement during four phases were 325, 185, 112, and 69 HU with protocol A. Corresponding values were 344, 266, 121, and 73 HU with protocol B. During all phases, aortic enhancement was significantly higher with protocol B (P = .046, P < .001, P < .001, and P = .002). Hepatic enhancement during four phases was 6, 21, 48, and 34 HU with protocol A. Corresponding values were 3, 17, 47, and 35 HU with protocol B. Hepatic enhancement was significantly higher with protocol A during first and second phases (P < .001 for both), although there was no significant difference between protocols during third and fourth phases (P = .778 and P = .178, respectively). Medians of tumor-to-liver contrast during four phases were 22, 34, 0.5, and –1.1 HU with protocol A. Corresponding values were 23, 45, 0, and –8.6 HU with protocol B. Tumor-to-liver contrast was significantly higher with protocol B during second phase (P = .049), although there was no difference between protocols during other phases.

CONCLUSION: When total iodine dose was adjusted to body weight and injection duration was fixed, rapid administration of moderate concentration of contrast material was more effective for depiction of hypervascular HCC than was high concentration of contrast material.

© RSNA, 2004

Index terms: Aorta, CT, 56.12112, 56.12114, 56.12115 • Computed tomography (CT), contrast media • Liver, CT, 761.12112, 761.12114, 761.12115 • Liver, diseases, 761.323 • Liver neoplasms, CT, 761.12112, 761.12114, 761.12115




This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
X. Ma, A. E. Samir, N.-S. Holalkere, and D. V. Sahani
Optimal Arterial Phase Imaging for Detection of Hypervascular Hepatocellular Carcinoma Determined by Continuous Image Capture on 16-MDCT
Am. J. Roentgenol., September 1, 2008; 191(3): 772 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
X. Fei, X. Du, Q. Yang, Y. Shen, P. Li, J. Liao, and K. Li
64-MDCT Coronary Angiography: Phantom Study of Effects of Vascular Attenuation on Detection of Coronary Stenosis
Am. J. Roentgenol., July 1, 2008; 191(1): 43 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. F. Behrendt, A. H. Mahnken, S. Stanzel, P. Seidensticker, E. Jost, R. W. Gunther, and G. Muhlenbruch
Intraindividual Comparison of Contrast Media Concentrations for Combined Abdominal and Thoracic MDCT
Am. J. Roentgenol., July 1, 2008; 191(1): 145 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
Y. Yanaga, K. Awai, T. Nakaura, T. Namimoto, S. Oda, Y. Funama, and Y. Yamashita
Optimal Contrast Dose for Depiction of Hypervascular Hepatocellular Carcinoma at Dynamic CT Using 64-MDCT
Am. J. Roentgenol., April 1, 2008; 190(4): 1003 - 1009.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. T. Schindera, R. C. Nelson, S. Mukundan Jr, E. K. Paulson, T. A. Jaffe, C. M. Miller, D. M. DeLong, K. Kawaji, T. T. Yoshizumi, and E. Samei
Hypervascular Liver Tumors: Low Tube Voltage, High Tube Current Multi Detector Row CT for Enhanced Detection Phantom Study
Radiology, December 1, 2007; 246(1): 125 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
H.M. Silvennoinen, L.M. Hamberg, L. Valanne, and G.J. Hunter
Increasing Contrast Agent Concentration Improves Enhancement in First-Pass CT Perfusion
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1299 - 1303.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. Cademartiri, N. R. Mollet, P. A. Lemos, F. Saia, M. Midiri, P. J. de Feyter, and G. P. Krestin
Higher Intracoronary Attenuation Improves Diagnostic Accuracy in MDCT Coronary Angiography
Am. J. Roentgenol., October 1, 2006; 187(4): W430 - W433.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. Kubo, E. Tadamura, M. Yamamuro, R. Hosokawa, T. Kimura, T. Kita, M. Komeda, and K. Togashi
Thoracoabdominal-aortoiliac MDCT angiography using reduced dose of contrast material.
Am. J. Roentgenol., August 1, 2006; 187(2): 548 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
W. Schima, R. Hammerstingl, C. Catalano, L. Marti-Bonmati, E. J. Rummeny, F. T. Montero, A. Dirisamer, B. Westermayer, M. Bellomi, D. Brisbois, et al.
Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate.
Am. J. Roentgenol., June 1, 2006; 186(6): 1571 - 1579.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. T. Johnson and E. K. Fishman
IV Contrast Selection for MDCT: Current Thoughts and Practice
Am. J. Roentgenol., February 1, 2006; 186(2): 406 - 415.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
K. T. Bae, K. Awai, and Y. Yamashita
Comparison of Moderate versus High Concentration of Contrast Media Injected at the Same Total Iodine Dose and Fixed Injection Duration * Drs Awai and Yamashita respond:
Radiology, August 1, 2005; 236(2): 740 - 741.
[Full Text] [PDF]